COVID-19

COVID-19 Insights: Sickle Cell and Thalassemia

SARS-COV-2 and blood disorders

What are inhibitors?

For example factors VIII or IX clotting factors for hemophilia

Are patients with blood disorders at a higher risk?
Some patients with hemophilia may develop inhibitors and doctors may prescribe them immunosuppressants. These are medicines that suppress the immune system. They may, therefore, make patients more susceptible to infections including SARS-CoV-2.

Plasma therapy is safe from SARS-COV-2 pathogen transmission. Statement by HFA

PPTA Statement

WORLD FEDERATION OF HEMOPHILIA RECOMMENDATIONS FOR HEMOPHILIA PATIENTS

Pandemic and hemoglobin disorders
Sickle cell anemia
Cell sickling in the hypoxic and acidic environment leading to the acute chest syndrome. Plus carboxyamide is mild immunosuppressant that may results in additional risk.

Hemophilia and COVID-19
von Willebrand Disease and Hemophilia A

Hypercoagulopathy

Desmopressin (DDAVP)

G6PD deficiency and COVID-19

How I treat vWF disease